New highly selective antitumor photodynamic therapy agents synthesized

April 18, 2018, Lobachevsky University
The structure of the proposed photosensitizer conjugate. Credit: Lobachevsky University

A team of researchers from Lobachevsky University (Nizhny Novgorod, Russia) headed by Professor Alexei Fedorov, chair of the Organic Chemistry Department, is working to create a new generation of targeted anti-cancer drugs for photodynamic therapy.

Today, there are many ways to fight cancer. The problem is that every case of cancer is unique in its own way, and there is no single winning treatment strategy. Doctors can try to combine different therapies and observe the best response to their combination.

On widely used treatment method is . "In this method, a photosensitizer is injected into the bloodstream or applied to the affected area of the skin, and used to destroy tumors. When this molecule is activated by light, a number of chain processes are initiated that result in the death of tumor cells," Fedorov notes.

However, there are some problems associated with the application of this approach. Current photosensitizer drugs have a number of serious advantages, but one significant drawback: The selectivity of their accumulation in tumor tissue is very low. In other words, when these drugs are administered to the patient, they are distributed almost evenly between healthy tissues and those affected by tumors. It is quite obvious that this balance should be shifted toward predominant accumulation in tumors. Current efforts of researchers in many countries are focused on achieving this goal.

New highly selective antitumor photodynamic therapy agents synthesized
Confocal images of cells after incubation with the photosensitizer. Credit: Lobachevsky University

To address this problem, the team of Prof. Fedorov used the concept of the "chemistry of conjugates," molecules consisting of several active parts. The researchers decided to combine the therapeutic properties of classical photosensitizers based on natural chlorophyll with highly selective molecules based on targeted drugs. The idea is simple enough: to synthesize two separate molecules with different but important properties, and then combine them to produce one molecule with a full set of properties. As a result of this approach, a significant improvement in the pharmacological parameters of was expected, due to the targeted portion of the molecule.

With the help of the scientists from the Research Institute of Chemistry of Macroheterocyclic Compounds (Ivanovo), the starting material was isolated to create the photosensitizer part of the conjugate from the Arthrospira blue-green algae. Based on this material, the targeted compounds were obtained at the Lobachevsky University.

Biological tests conducted on cell and animal models at the Lobachevsky University Biophysics Department have shown that the synthesized molecules accumulate tens of times more efficiently and faster than containing only the photosensitizer part. The results of this work that were published in the European Journal of Medicinal Chemistry in January 2018 open up the possibilities for creating a new class of drugs for photodynamic therapy.

However, this was just the first stage of the project. After obtaining the initial positive results, a vast field opens for optimizing the structure of the molecule in order to reduce the toxicity of drugs and to increase their selective effect on tissues.

Currently, work is under way to create the next generation of conjugates that will surpass their predecessors in most aspects. Later, preclinical trials are planned for the most effective new compounds.

Explore further: A unique amino acid for brain cancer therapy

Related Stories

A unique amino acid for brain cancer therapy

June 23, 2017

Photodynamic therapy is often used to treat brain tumors because of its specificity—it can target very small regions containing cancerous cells while sparing the normal cells around it from damage. It works by injecting ...

Nanoparticles Yield Safer Light-Activated Cancer Therapy

September 27, 2007

Photodynamic therapy, in which light activates a chemical known as a photosensitizer, triggering the production of cell-killing reactive oxygen, has proven itself as an effective therapy for a limited number of cancers.

Lighting the way to targeted therapies and fewer side effects

April 4, 2018

Side effects from drugs working in non-target locations within the body can cause debilitating symptoms, often resulting in patients stopping their course of treatment early. But according to an article in Chemical & Engineering ...

Polymer Nanoparticle Kills Tumors

January 12, 2006

Photodynamic therapy (PDT), which uses a light-sensitive chemical known as a photosensitizer to produce cell-killing “reactive oxygen,” has become an important option for the treatment of esophageal cancer and non-small ...

Recommended for you

Targeting 'hidden pocket' for treatment of stroke and seizure

January 19, 2019

The ideal drug is one that only affects the exact cells and neurons it is designed to treat, without unwanted side effects. This concept is especially important when treating the delicate and complex human brain. Now, scientists ...

Using bacteria to create a water filter that kills bacteria

January 18, 2019

More than one in 10 people in the world lack basic drinking water access, and by 2025, half of the world's population will be living in water-stressed areas, which is why access to clean water is one of the National Academy ...

Hand-knitted molecules

January 18, 2019

Molecules are usually formed in reaction vessels or laboratory flasks. An Empa research team has now succeeded in producing molecules between two microscopically small, movable gold tips – in a sense as a "hand-knitted" ...

Artificially produced cells communicate with each other

January 18, 2019

Friedrich Simmel and Aurore Dupin, researchers at the Technical University of Munich (TUM), have for the first time created artificial cell assemblies that can communicate with each other. The cells, separated by fatty membranes, ...

This computer program makes pharma patents airtight

January 17, 2019

Routes to making life-saving medications and other pharmaceutical compounds are among the most carefully protected trade secrets in global industry. Building on recent work programming computers to identify synthetic pathways ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.